MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit

By SquaredTown on February 7, 2026

MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit

NEW YORK, Feb. 7, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of American Depositary Shares ("ADS") of Mereo BioPharma Group plc (NASDAQ: MREO) between June 5, 2023, and December 26, 2025. A class action...

Read More